A.P. Pharma, of Redwood City, dislosed that it raised $37.5 million back in June through private placement of stock. That should give it time to complete trials of a drug for “the prevention of chemotherapy-induced nausea and vomiting.”
The extra dough will also apparently be enough to keep the pharmaceutical company from being delisted by Nasdaq.
